Information Provided By:
Fly News Breaks for July 10, 2019
CLB
Jul 10, 2019 | 06:57 EDT
BofA Merrill Lynch analyst Chase Mulvehill upgraded Core Laboratories to Buy from Neutral as he sees the stock being set to reverse its outperformance after having fallen 10% year-to-date. Management has increasing confidence in a Reservoir Description ramp in the second half, said Mulvehill, who noted the "extremely high" correlation of RD and offshore rig activity. He maintains a $63 price target on Core Labs shares.
News For CLB From the Last 2 Days
CLB
CLB
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.